[144] PUMA BIOTECHNOLOGY INC SEC Filing

Rhea-AI Filing Summary

Par Pacific Holdings, Inc. (PARR) – Form 4 insider transaction

Director Curtis Anastasio reported several equity transactions dated 5 July 2025:

• RSU vesting: 969 restricted stock units vested and were converted into an equal number of common shares (Transaction Code M in Table II). These shares appear in Table I under Code J as 461 and 508 shares, respectively, at an indicative price of $31.45.
• New equity grant: An additional 795 restricted shares were granted (Transaction Code A). These will vest fully and be delivered on 5 July 2026.

After the transactions, Anastasio’s direct holdings increased to 107,215 common shares. No derivative positions remain outstanding other than the new RSU grant.

All activity was non-open-market and relates to the company’s equity compensation plan, so there is no cash outlay or open-market buying signal. While the additional ownership modestly aligns director incentives with shareholders, the scale (≈ 1,764 shares, ≈ $55 k value) is small relative to PARR’s market capitalization and is not expected to influence valuation or liquidity.

Positive

• Director’s ownership increases by 1,764 shares, modestly enhancing alignment with shareholders.

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine RSU vesting and grant; minor ownership increase, neutral market impact.

The filing shows standard compensation events: 969 RSUs vested and converted, plus 795 new RSUs awarded. Total direct holdings rise to 107,215 shares, worth roughly $3.4 million at $31.45 per share. There was no open-market purchase or sale, and the transactions do not alter the company’s capital structure. Insider alignment improves incrementally, but the modest size versus Par Pacific’s ~60 million shares outstanding renders the news non-material for valuation or momentum investors.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5587	19740.55	49638093	07/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/07/2025	Restricted Stock Vesting	Issuer			5587	07/07/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Par Pacific (PARR) shares did Director Curtis Anastasio acquire on 5 July 2025?

He received 1,764 common shares (969 from RSU vesting and 795 as a new grant).

What is Director Anastasio’s total direct ownership after the Form 4 transactions?

His direct holdings stand at 107,215 PARR shares.

Were the shares bought on the open market?

No. All shares were acquired through equity compensation events (RSU vesting and restricted stock grant).

When will the newly granted 795 restricted shares vest?

They will vest in full on 5 July 2026.

Does the Form 4 indicate any share sales by the director?

No. The filing shows only acquisitions; there were no dispositions reported.